Skip to main content
. 2013 Nov 12;123(1):70–77. doi: 10.1182/blood-2013-06-509463

Figure 1.

Figure 1

Treatment outcome of the DS-ALL and nonDS-ALL patients. The continuous lines represent DS-ALL patients, and the dotted lines represent non–DS-ALL patients. The red line represents OS, the blue line EFS, the green line the cumulative incidence of TRM, and the light blue line CIR. SE, standard error.